Craig Barrows

Craig Barrows discloses dealings in 2 companies, chiefly ImmunoGen, Inc. and Mercury Systems Inc. We count 21 filings; the first trade dates from 20 February 2006 and the latest from 24 February 2020.

Both buying and selling appear: 1 purchase worth €15k, against 8 sales worth €716k. Taken together, the sales exceed the purchases by €701k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants and 5 option exercises. In 2020 alone, the filings show no purchases and 1 sale.

The latest filing, published on 25 February 2020, reports an open-market sale of €76k in ImmunoGen, Inc. The last purchase on record was published on 3 November 2016, which is 3,658 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.